Docegen Injection is an anticancer medication used in chemotherapy for the treatment of various cancers, including breast cancer, lung cancer, prostate cancer, and ovarian cancer. It contains Docetaxel, a taxane-class chemotherapy drug that works by inhibiting cancer cell division and promoting cell death.

Mechanism of Action:

Docegen (Docetaxel) disrupts the microtubule structures inside cancer cells, which are essential for cell division. By stabilizing these microtubules and preventing their breakdown, Docegen stops cancer cells from multiplying and eventually leads to their death.

Administration:

• Given as an intravenous (IV) infusion under medical supervision.
• The dosage and frequency depend on the type and stage of cancer, body surface area, and overall patient condition.
• Often used alone or in combination with other chemotherapy agents for enhanced effectiveness.

Possible Side Effects:

• Fatigue and weakness
• Nausea and vomiting
• Hair loss (temporary)
• Low white blood cell count (increased risk of infections)
• Fluid retention and swelling
• Neuropathy (tingling or numbness in hands and feet)
• Mouth sores

Precautions:

• Blood tests are required to monitor blood cell levels and liver function.
• Pre-medications (such as corticosteroids) may be given to reduce the risk of allergic reactions and fluid retention.
• Caution is advised for patients with liver disease or weakened immune systems.
• Not recommended during pregnancy or breastfeeding.

Docegen Injection plays a crucial role in cancer treatment by slowing tumor growth and improving survival outcomes when administered under proper medical guidance.